NAIROBI, Kenya – Kenya and the United States have officially launched a landmark five-year health cooperation programme valued at $1.6 billion (KSh207 billion), bringing an end to months of legal disputes and public debate that had delayed its implementation.
The agreement, known as the Kenya–U.S. Health Cooperation Partnership, is expected to strengthen Kenya’s healthcare systems, enhance disease surveillance capabilities, and improve the country’s preparedness for future public health emergencies.
The breakthrough was confirmed following a meeting in Nairobi between Treasury Principal Secretary Chris Kiptoo and U.S. Chargé d’Affaires Susan Burns, where both governments finalized plans to operationalize the programme.
Speaking after the meeting, Kiptoo said the partnership reflects the long-standing cooperation between Kenya and the United States and will support critical investments across the health sector.
The programme will focus on several priority areas, including disease surveillance, outbreak detection and response, laboratory capacity enhancement, medical supply chain management, digital health infrastructure, and the transition and support of frontline healthcare workers.
Government officials say the initiative will significantly improve Kenya’s ability to respond to emerging health threats while expanding access to quality healthcare services across the country.
The partnership is also expected to bolster emergency preparedness measures and strengthen health systems at both national and county levels.
Despite its official launch, the agreement has faced sustained scrutiny from civil society organizations, legal experts, and some lawmakers who questioned the process through which it was negotiated.
Among the most vocal critics has been Okiya Omtatah, who argued that the agreement lacked adequate public participation and parliamentary oversight before being finalized.
Critics maintained that an international commitment of such financial and strategic significance should undergo broader public scrutiny to ensure transparency and accountability.
Concerns have also emerged regarding provisions related to health data sharing and legal protections for foreign personnel involved in the programme. Organizations including the Consumers Federation of Kenya and Katiba Institute warned that aspects of the agreement could potentially expose sensitive patient information, particularly data related to HIV and tuberculosis treatment.
Meanwhile, health rights advocacy group KELIN expressed concerns over clauses that grant legal immunity to certain U.S. personnel and contractors, arguing that such provisions could affect accountability mechanisms in the event of disputes or allegations of misconduct.
However, U.S. officials have consistently maintained that Kenya’s data protection laws remain fully applicable under the agreement and that any information shared will be aggregated and handled in compliance with privacy regulations.
Beyond healthcare, the agreement underscores the broader economic and diplomatic relationship between Kenya and the United States. Kiptoo noted that American companies continue to play a significant role in Kenya’s economy through investment, job creation, innovation, and skills development.
As implementation begins, the partnership is expected to deliver substantial support to Kenya’s healthcare sector. However, debate surrounding transparency, financial commitments, and legal safeguards is likely to continue as stakeholders monitor the programme’s rollout over the next five years.
About The Author
